Vnitr Lek 2021, 67(2):109-113 | DOI: 10.36290/vnl.2021.023

Hemodynamic significant pericardial effusion as a possible rare extraintestinal manifestation of Crohn's disease

Barbora Pipek^1-3, Martin Pleva^3-5, Petr Fojtík^1,3, Přemysl Falt²

¹ Centrum péče o zažívací trakt, Nemocnice AGEL Ostrava Vítkovice, a. s.

² II. interní klinika - gastroenterologická a geriatrická LF UP a FN Olomouc

³ Ostravská univerzita - Lékařská fakulta, Ostrava

⁴ Interní oddělení - vaskulární centrum, Nemocnice AGEL Ostrava Vítkovice, a. s.

⁵ Kardiologické oddělení, Nemocnice AGEL Třinec Podlesí, a. s.

Crohn's disease (CN) and ulcerative colitis (UC) belong to a group of diseases called inflammatory bowel diseases (IBD). The etiology of these illnesses is still not known, however, they are diagnosed mainly at a young age and 1/3 of these patients develop extraintestinal manifestation of the disease. These include arthropathy, ocular and cutaneous manifestations of this inflammation, metabolic bone disease, and hepatobiliary or urological disease. The treatment of extraintestinal manifestations is similar to the treatment for the main disease and frequently consists of immunosuppression. Pericardial effusion or pericarditis is a rare extraintestinal manifestation of Crohn's disease or ulcerative colitis. In the differential diagnosis of unclear pericardial involvement, we have to consider the microbial etiology, side effects of administered treatment or systemic diseases.

Keywords: Crohn's disease, extraintestinal manifestations of IBD, pericardial effusion, biologic therapy, adalimumab, hepatitis C.

Published: April 21, 2021  Show citation